Investment in Women’s Health reached
Leveraging SVB’s proprietary data and analysis, the 2025 Innovation in Women’s Health Report explores the current fundraising landscape, key trends, and emerging innovations across the sector.
“Investment in women’s health continues to reach new milestones, driven by a growing recognition of the ways in which health conditions impact women differently,” said Raysa Bousleiman, co-author of the report and senior vice president for Investor Coverage in Life Science and Healthcare at SVB. “While 2025 may present challenges, the long-term potential of the sector is clear, and we expect continued investment focused on addressing the unmet healthcare needs for women.”
Key findings from the Innovation in Women’s Health Report include:
- Increased awareness is fueling investment: Investment in women’s health has grown significantly. In 2024, the sector saw a
55% increase in VC investment, outpacing growth in the broader healthcare industry. - Sector innovation follows broader healthcare trends: As the women’s health sector evolves, it is increasingly diversified, following in the footsteps of the wider healthcare industry. Investment in healthtech solutions dropped from
54% in 2021 to38% in 2024, while biopharma investment surged to34% , up from just12% in 2021. - Women’s health investment stages now mirror the larger healthcare sector: In 2023, seed and Series A deals made up
83% of women’s health investments, compared to72% in the overall healthcare space. The gap narrowed in 2024, with seed and Series A deals representing70% and67% , respectively, of total deals in each sector. - Precision medicine and personalized health are taking center stage: Funding flooded into early-stage startups focused on filling gaps in clinical pathway guidelines for women’s health. In 2024, VC investment in precision medical startups totaled
, up from$3.6 billion in 2023.$1.4 billion - Exits remain a challenge but potential is growing: The lack of exits in women’s health has raised concerns about the sector’s potential, with investors noting difficulty in finding comparable companies and doubts about large returns. However, recent IPOs and M&A activity in related areas suggest that women’s health could help break the exit logjam in the broader healthcare market.
Learn More
For a preview of the Innovation in Women’s Heath report, click here: Innovation in Women’s Health | Silicon Valley Bank
SVB is a leader in providing market insights on sectors across the innovation economy. For the complete library of SVB’s signature reports, please visit Market Research Industry Trends & Insights | Silicon Valley Bank (svb.com)
About Silicon Valley Bank
Silicon Valley Bank (SVB), a division of First Citizens Bank, is the bank of some of the world’s most innovative companies and investors. SVB provides commercial banking to companies in the technology, life science and healthcare, private equity, and venture capital industries. SVB operates in centers of innovation throughout
View original content to download multimedia:https://www.prnewswire.com/news-releases/venture-capital-investment-in-womens-health-startups-reaching-record-highs-silicon-valley-bank-releases-report-302417682.html
SOURCE Silicon Valley Bank